MarketBeat reported a Moderate Buy consensus rating for Genelux, while Benchmark reissued a speculative buy rating, and an insider sold shares.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported a Moderate Buy consensus rating for Genelux, while Benchmark reissued a speculative buy rating, and an insider sold shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Genelux Corporation
biopharmaceutical company
Nothing else this week.
-
MarketBeat
American personal finance blog
-
Benchmark
venture capital firm
Related events
- Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.
- Global Mofy AI Limited was listed on the stock exchange and received a consensus rating from MarketBeat.
- MarketBeat reported consensus ratings for FedEx stock on June 6, 2026.
- MarketBeat reports consensus ratings while Raymond James Financial raises its price objective and Truist Financial reaffirms a buy rating for Hewlett Packard Enterprise.
- Co-Diagnostics filed a stock purchase with the SEC and received stock rating data from MarketBeat.